Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A. M. Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer, Nicola S. Meagher, Sian Fereday, Laura Twomey, Kathleen I. Pishas, Therese Hoang, Adelyn Bolithon, Nadia Traficante, Kathryn Alsop, Elizabeth L. Christie, Eun-Young Kang, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Jennifer Alsop, Matthias W. Beckmann, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Michael E. Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L. Cushing-Haugen, Cezary Cybulski, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Simon A. Gayther, Aleksandra Gentry-Maharaj, C. Blake Gilks, Paul R. Harnett, Holly R. Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, AOCS Group, Brenda Y. Hernandez, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E. Jones, Scott H. Kaufmann, Catherine J. Kennedy, Tomasz Kluz, Jennifer M. Koziak, Björg Kristjansdottir, Nhu D. Le, Marcin Lener, Jenny Lester, Jan Lubiński, Constantina Mateoiu, Sandra Orsulic, Matthias Ruebner, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Mark E. Sherman, Yurii B. Shvetsov, Naveena Singh, T. Rinda Soong, Helen Steed, Paniti Sukumvanich, Aline Talhouk, Sarah E. Taylor, Robert A. Vierkant, Chen Wang, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Michael S. Anglesio, Andrew Berchuck, James D. Brenton, Ian Campbell, Linda S. Cook, Jennifer A. Doherty, Peter A. Fasching, Renée T. Fortner, Marc T. Goodman, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Linda E. Kelemen, Usha Menon, Francesmary Modugno, Paul D.P. Pharoah, Joellen M. Schildkraut, Karin Sundfeldt, Anthony J. Swerdlow, Ellen L. Goode, Anna DeFazio, Martin Köbel, Susan J. Ramus, David D. L. Bowtell, Dale W. Garsed
medRxiv 2023.11.09.23298321; doi: https://doi.org/10.1101/2023.11.09.23298321
